Soybean Bioactive Peptides and Their Functional Properties

about

Soybean Bioactive Peptides and Their Functional Properties

Item

http://www.wikidata.org/entity/Q58773319

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Soybean Bioactive Peptides and Their Functional Properties

@en

Soybean Bioactive Peptides and Their Functional Properties

@nl

type

Item

label

Soybean Bioactive Peptides and Their Functional Properties

@en

Soybean Bioactive Peptides and Their Functional Properties

@nl

prefLabel

Soybean Bioactive Peptides and Their Functional Properties

@en

Soybean Bioactive Peptides and Their Functional Properties

@nl

P1476

Soybean Bioactive Peptides and Their Functional Properties

@en

P2093

Chao-Wu Xiao

http://www.w3.org/2001/XMLSchema#string

Cynthia Chatterjee

http://www.w3.org/2001/XMLSchema#string

Stephen Gleddie

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature

Interaction of phytoestrogens with estrogen receptors alpha and beta

Chemopreventive property of a soybean peptide (lunasin) that binds to deacetylated histones and inhibits acetylation

Presence of lunasin in plasma of men after soy protein consumption.

Development of difluoromethyl-ornithine and Bowman-Birk inhibitor as chemopreventive agents by assessment of relevant biomarker modulation: some lessons learned.

Health effects of soy protein and isoflavones in humans.

Analysis of soybean protein-derived peptides and the effect of cultivar, environmental conditions, and processing on lunasin concentration in soybean and soy products.

Lunasin suppresses E1A-mediated transformation of mammalian cells but does not inhibit growth of immortalized and established cancer cell lines.

"Potential health benefits of lunasin: a multifaceted soy-derived bioactive peptide".

Soymorphin-5, a soy-derived μ-opioid peptide, decreases glucose and triglyceride levels through activating adiponectin and PPARα systems in diabetic KKAy mice.

P304

1211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3390/NU10091211

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30200502

http://www.w3.org/2001/XMLSchema#string

P921

P932

6164536

http://www.w3.org/2001/XMLSchema#string